INFLAMMATION AT INTERFACES
LIVE

Serial Number

79080850

Owner

Christian-Albrechts- Universität zu Kiel

Attorney

Syed Abedi

Filing Date

Feb 22, 2010

Add to watchlist:

No watchlists yet
View on USPTO

INFLAMMATION AT INTERFACES Trademark

Serial Number: 79080850 • Registration: 3972615

INFLAMMATION AT INTERFACES is a trademark filed by Christian-Albrechts- Universität zu Kiel on February 22, 2010. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Christian-Albrechts- Universität zu Kiel (2 trademarks)

Christian-Albrechts-Platz 4
Kiel 24118 , DE

Entity Type: 03

Trademark Details

Filing Date

February 22, 2010

Registration Date

June 7, 2011

Published for Opposition

March 22, 2011

Goods & Services

Education and training, in particular arranging and conducting of seminars and workshops and academic enrichment programs in the field of inflammation medicine for young academics

[ Business management and administration, operation of business for others, namely, medical care and research organizations, in particular in the field of inflammation medicine; organization and arrangement of trade exhibitions and trade fairs for scientific businesses, commercial and advertising purposes; business marketing services and public relations; distribution of advertising material; procurement of service contracts for others, namely, procuring of labor contracting services for others ]

[ Medical services, in particular medical and clinical analysis in the nature of medical analysis of inflammation medicine and inflammation related conditions; therapeutic and medical treatment and attendance, namely, providing medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns, and including analysis of patient's environment, analysis of life circumstances, genetically disposition analysis, and hereditary family analysis; services of a hospital; medical care, namely, medical care for inflammation related conditions ]

Scientific services and research activities, in particular scientific research for medical purposes, namely providing medical research, clinical research and interdisciplinary medical research in the field of inflammation medicine, including fundamental research, contract research and clinical trials; pharmaceutical drug development services and conducting clinical trials featuring the application of new therapies and therapy approaches and diagnostic methods for scientific purposes; scientific study and research in the field of inflammation medicine featuring reports and surveys; industrial analysis, namely, conducting technical project studies in the field of high-throughput of molecular diagnostics, and translational and clinical research based on molecular makeup of patients

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 17, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2025 REAP
PARTIAL INVALIDATION PROCESSED BY THE IB
Sep 25, 2022 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Aug 23, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 23, 2022 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 25, 2022 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Oct 25, 2021 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Oct 25, 2021 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 25, 2021 APRE
TEAS SECTION 71 RECEIVED
May 20, 2021 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Dec 4, 2020 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 7, 2020 REM4
INTERNATIONAL REGISTRATION RENEWED
Apr 16, 2020 RNWL
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Dec 1, 2018 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 16, 2018 INPR
PARTIAL INVALIDATION PROCESSED BY THE IB
May 4, 2018 INNP
GENERIC MADRID TRANSACTION SENT TO IB
Mar 15, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
Mar 15, 2018 XXCR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 5, 2018 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jul 5, 2017 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jul 5, 2017 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 3, 2017 APRE
TEAS SECTION 71 & 15 RECEIVED
Jun 6, 2017 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 25, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 27, 2011 FICS
FINAL DISPOSITION PROCESSED
Oct 27, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 7, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 7, 2011 R.PR
PUBLISHED FOR OPPOSITION
Mar 22, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 3, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 3, 2011 OP2R
NOTICE OF PUBLICATION
Mar 2, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 16, 2011 PREV
ASSIGNED TO LIE
Feb 11, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 19, 2011 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 19, 2011 ERFR
FINAL REFUSAL MAILED
Dec 3, 2010 CNFR
FINAL REFUSAL WRITTEN
Dec 2, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2010 TROA
REFUSAL PROCESSED BY IB
Jul 2, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 3, 2010 RFCS
REFUSAL PROCESSED BY MPU
Jun 3, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 3, 2010 RFCR
NON-FINAL ACTION WRITTEN
Jun 2, 2010 CNRT
ASSIGNED TO EXAMINER
May 26, 2010 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 20, 2010 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 15, 2010 REPR